Efficacy of Left Bundle Branch Area Pacing Versus Biventricular Pacing in Cardiac Resynchronization Therapy Patients: Select Site - Cohort Study

Jenish P. Shroff,Deep Chandh Raja,Lukah Q. Tuan,Sreevilasam P. Abhilash,Abhinav Mehta,Walter P. Abhayaratna,Prashanthan Sanders,Rajeev K. Pathak
DOI: https://doi.org/10.1016/j.hrthm.2024.02.024
IF: 6.779
2024-02-17
Heart Rhythm
Abstract:Background Cardiac resynchronization therapy (CRT) is typically attempted with biventricular pacing. One-third of patients are non-responders. Left bundle branch area pacing (LBBAP) has been evaluated as an alternative means. Objective To assess the feasibility and clinical response of permanent LBBAP as an alternative to biventricular pacing. Methods Of 479 consecutive patients referred with heart failure (HF), 50 with biventricular pacing (BiV-CRT) and 51 with left bundle branch area pacing (LBBAP-CRT) were included in this analysis after study exclusions. Quality-of-Life (QoL) assessments; electrocardiogram and echocardiographic measurements; and New York Heart Association (NYHA) class were obtained at baseline and at 6-monthly Intervals. Results There were no differences in baseline characteristics between groups (P=NS). Clinical outcomes such as left ventricular ejection fraction (LVEF), left ventricular end-systolic volume (LVESV), QoL and NYHA class were significantly improved for both pacing groups compared to baseline. LBBAP-CRT group showed greater improvement in LVEF at 6- (p=0.001) and 12-months (P=0.021), accompanied by greater reduction in LVESV (P=0.007). QRS <120 ms (baseline 160.82±21.35ms vs 161.08±24.48ms) was achieved in 30% in BiV-CRT vs 71% in LBBAP-CRT group (P=<0.001). Improvement in NYHA class (P=0.031) and QoL index was greater (P=0.014). Reduced HF admissions (P=0.003) and healthcare utilisation (P<0.05), and improved lead performance (p<0.001) were observed in LBBAP-CRT group. Conclusions LBBAP-CRT is a feasible and effective cardiac resynchronisation therapy. It results into a meaningful improvement in QoL and reduction in healthcare utilisation. This can be offered as an alternative to BiV-CRT or potentially as first-line therapy.
cardiac & cardiovascular systems
What problem does this paper attempt to address?